How Does Type 1 Diabetes Develop?

Despite decades of acknowledging that a loss of insulin-producing pancreatic β-cells is central to the disorder now referred to as type 1 diabetes, the specific roles for genetic susceptibility, environmental factors, the immune system, and β-cells themselves in the pathogenic processes underlying the disorder remain unclear (1,2). Looking back over this period, one can identify a handful of conceptualizations that were seminal in their attempt to address this issue, including that posited by Dr. Gian Franco Bottazzo in his 1986 article, “Death of a Beta Cell: Homicide or Suicide?” (3). Bottazzo questioned whether the disorder’s pathogenesis weighed more heavily (or exclusively) on processes related to immune responsiveness (i.e., homicide) or the fragility of β-cells leading to self-destruction (i.e., suicide). Many reasons exist with respect to why we are in this knowledge void, including the exceedingly complex nature of type 1 diabetes, the likelihood that this disorder may represent a disease with more than one etiology, as well as the complex interplay of genetics, the immune system, and the environment. One limitation in solving important pathogenic questions in type 1 diabetes has likely been suboptimal cross-talk among geneticists, epidemiologists, endocrinologists, and others. Our own approach to overcoming this limitation has been to try to increase collaboration between cell biologists and immunologists as a critical step in closing knowledge gaps regarding the disorder’s pathogenesis. The opinion put forward within this Perspectives article by this group of authors is one where multiple and clearly unique properties of the β-cell appear fundamental to the loss of immune tolerance, accompanied by immune-mediated destruction. The Bottazzo article (3) was unique in its form of presentation, in that the prose represented the equivalent workings of a legal stenographer recording the debate between two counsels: one for the prosecution (i.e., β-cell homicide) the other representing the …

[1]  J. Bollyky,et al.  Short-term IL-1beta blockade reduces monocyte CD11b integrin expression in an IL-8 dependent fashion in patients with type 1 diabetes. , 2010, Clinical immunology.

[2]  M. Prentki,et al.  Glucolipotoxicity age-dependently impairs beta cell function in rats despite a marked increase in beta cell mass , 2010, Diabetologia.

[3]  P. Marrack,et al.  Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register , 2010, Proceedings of the National Academy of Sciences.

[4]  P. Santamaria,et al.  The long and winding road to understanding and conquering type 1 diabetes. , 2010, Immunity.

[5]  M. Andersen,et al.  ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. , 2010, Toxicology and applied pharmacology.

[6]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[7]  E. Unanue,et al.  In Autoimmune Diabetes Unique Autoreactive T Cells Recognize Insulin Peptides Generated in the Islets of Langerhans , 2010, Nature Immunology.

[8]  M. J. MacDonald,et al.  Regulation of insulin secretion: role of mitochondrial signalling , 2010, Diabetologia.

[9]  Nichole Reisdorph,et al.  Chromogranin A is an autoantigen in type 1 diabetes , 2010, Nature Immunology.

[10]  M. Donath,et al.  Blockade of interleukin 1 in type 1 diabetes mellitus , 2010, Nature Reviews Endocrinology.

[11]  M. Peakman,et al.  Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes , 2010, Nature Reviews Immunology.

[12]  S. Bonner-Weir,et al.  Dimorphic histopathology of long-standing childhood-onset diabetes , 2010, Diabetologia.

[13]  R. Bottino,et al.  Long‐Term Controlled Normoglycemia in Diabetic Non‐Human Primates After Transplantation with hCD46 Transgenic Porcine Islets , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  Darrell M. Wilson,et al.  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. , 2009, The New England journal of medicine.

[15]  L. Harrison,et al.  Reappraising the stereotypes of diabetes in the modern diabetogenic environment , 2009, Nature Reviews Endocrinology.

[16]  P. Gottlieb,et al.  The honeymoon phase: intersection of metabolism and immunology , 2009, Current opinion in endocrinology, diabetes, and obesity.

[17]  K. Herold,et al.  Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage. , 2009, Endocrinology and metabolism clinics of North America.

[18]  A. Bhushan,et al.  Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. , 2009, Genes & development.

[19]  A. Tarakhovsky,et al.  Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. , 2009, Genes & development.

[20]  M. Foss,et al.  C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. , 2009, JAMA.

[21]  H. Thomas,et al.  Beta cell apoptosis in diabetes , 2009, Apoptosis.

[22]  R. Bottino,et al.  Recovery of Endogenous β-Cell Function in Nonhuman Primates After Chemical Diabetes Induction and Islet Transplantation , 2009, Diabetes.

[23]  A. Tengholm,et al.  Oscillatory control of insulin secretion , 2009, Molecular and Cellular Endocrinology.

[24]  M. Redondo,et al.  Concordance for islet autoimmunity among monozygotic twins. , 2008, The New England journal of medicine.

[25]  Johnny Ludvigsson,et al.  GAD treatment and insulin secretion in recent-onset type 1 diabetes. , 2008, The New England journal of medicine.

[26]  R. Rizza,et al.  β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.

[27]  R. Mirmira Faculty Opinions recommendation of Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. , 2008 .

[28]  R. Scharfmann,et al.  β Cells Can Be Generated from Endogenous Progenitors in Injured Adult Mouse Pancreas , 2008, Cell.

[29]  R. Robertson,et al.  Glucolipotoxicity : Fuel Excess and-Cell Dysfunction , 2008 .

[30]  R. Robertson,et al.  Glucolipotoxicity: fuel excess and beta-cell dysfunction. , 2008, Endocrine reviews.

[31]  B. Wicksteed,et al.  The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead? , 2007, Diabetes, obesity & metabolism.

[32]  U. Boggi,et al.  The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients , 2007, Diabetologia.

[33]  S. Malozowski,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[34]  D. Accili,et al.  Metabolic Diapause in Pancreatic β-Cells Expressing a Gain-of-function Mutant of the Forkhead Protein Foxo1* , 2007, Journal of Biological Chemistry.

[35]  A. Purcell,et al.  Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. , 2006, The Journal of clinical investigation.

[36]  William W Kwok,et al.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. , 2006, The Journal of clinical investigation.

[37]  Michel Goldman,et al.  Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. , 2005, The New England journal of medicine.

[38]  G. Eisenbarth,et al.  Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice , 2005, Nature.

[39]  D. Serreze,et al.  The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice , 2005, Immunological reviews.

[40]  I. Chang,et al.  Death effectors of β-cell apoptosis in type 1 diabetes , 2004 .

[41]  R. Hardman,et al.  Aberrant expression of Class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus , 1987, Diabetologia.

[42]  I. Chang,et al.  Death effectors of beta-cell apoptosis in type 1 diabetes. , 2004, Molecular genetics and metabolism.

[43]  Jerrold M. Olefsky,et al.  Diabetes mellitus : a fundamental and clinical text , 2004 .

[44]  M. Atkinson,et al.  Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination. , 2003, Diabetes care.

[45]  J. Killestein Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. , 2002, The New England journal of medicine.

[46]  D. D’Alessio,et al.  Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. , 2002, Diabetes.

[47]  M. Atkinson,et al.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment , 2001, The Lancet.

[48]  H. Thomas,et al.  Virus-induced autoimmune diabetes: most beta-cells die through inflammatory cytokines and not perforin from autoreactive (anti-viral) cytotoxic T-lymphocytes. , 2000, Diabetes.

[49]  M. Prentki,et al.  Metabolic control of -cell function , 2000 .

[50]  Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group. , 1998, Annals of internal medicine.

[51]  M. Hammami Diabetes Mellitus: A Fundamental and Clinical Text , 1997 .

[52]  M. Mcdaniel,et al.  A role for nitric oxide and other inflammatory mediators in cytokine-induced pancreatic beta-cell dysfunction and destruction. , 1997, Advances in experimental medicine and biology.

[53]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.

[54]  C. Newgard,et al.  Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.

[55]  M. V. von Herrath,et al.  How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. , 1994, Immunity.

[56]  K. Yamagata,et al.  Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. , 1993, The Journal of clinical investigation.

[57]  R. Thirlby,et al.  Severe Diabetes Induced in Subtotally Depancreatized Dogs by Sustained Hyperglycemia , 1988, Diabetes.

[58]  G. Bottazzo Death of a Beta Cell: Homicide or Suicide? , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[59]  S. Colagiuri,et al.  The Diabetes Control and Complications Trial , 1983, Henry Ford Hospital medical journal.

[60]  J. P. Moulin,et al.  The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. , 1982, Metabolism: clinical and experimental.

[61]  H. Okamoto,et al.  Translational control of proinsulin synthesis by glucose , 1980, Nature.

[62]  C. J. Hedeskov,et al.  The pentose cycle and insulin release in isolated mouse pancreatic islets during starvation. , 1975, The Biochemical journal.